These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8180120)

  • 1. Lack of inhibition of placental estrone sulfatase and aromatase enzymes by vitamin D3 and its analogs.
    Evans TR; Rowlands MG; Sahota SS; Coombes RC
    J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):563-6. PubMed ID: 8180120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
    Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
    Selcer KW; Jagannathan S; Rhodes ME; Li PK
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma.
    Evans TR; Rowlands MG; Jarman M; Coombes RC
    J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):493-9. PubMed ID: 1911438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen 3-sulfamates.
    Numazawa M; Tominaga T; Watari Y; Tada Y
    Steroids; 2006 May; 71(5):371-9. PubMed ID: 16476457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrone sulfate analogs as estrone sulfatase inhibitors.
    Li PK; Pillai R; Dibbelt L
    Steroids; 1995 Mar; 60(3):299-306. PubMed ID: 7792836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenicity, antiestrogenicity and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol.
    Selcer KW; Li PK
    J Steroid Biochem Mol Biol; 1995 Mar; 52(3):281-6. PubMed ID: 7696150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong inhibition of estrone-3-sulfatase activity by pregnenolone 16alpha-carbonitrile but not by several analogs lacking a 16alpha-nitrile group.
    Zhu BT; Kosh JW; Fu J; Cai MX; Xu S; Conney AH
    Steroids; 2000 Sep; 65(9):521-7. PubMed ID: 10978731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
    Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
    Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic studies on the formation of estrogens from dehydroepiandrosterone sulfate by human placental microsomes.
    Gibb W; Lavoie JC
    Endocrinology; 1984 Jun; 114(6):2323-9. PubMed ID: 6233132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors.
    Li PK; Milano S; Kluth L; Rhodes ME
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):41-8. PubMed ID: 9009236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
    Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
    Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
    Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.
    Pasqualini JR; Chetrite G; Blacker C; Feinstein MC; Delalonde L; Talbi M; Maloche C
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1460-4. PubMed ID: 8636351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer.
    Ahmed S; Owen CP; James K; Sampson L; Patel CK
    Curr Med Chem; 2002 Jan; 9(2):263-73. PubMed ID: 11860358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scavestrogen sulfamates: correlation between estrone sulfatase inhibiting and antioxidant effects.
    Römer W; Oettel M; Schwarz S
    Can J Physiol Pharmacol; 1998 Feb; 76(2):99-109. PubMed ID: 9635147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidal oxathiazine inhibitors of estrone sulfatase.
    Peters RH; Chao WR; Sato B; Shigeno K; Zaveri NT; Tanabe M
    Steroids; 2003 Jan; 68(1):97-110. PubMed ID: 12475726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.